EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High-resolution structural information of membrane-bound α-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599

Thomas C Schwarz iD, Andreas Beier, Karin Ledolter iD, Thomas Gossenreiter, Theresa Höfurthner, Markus Hartl iD, Terry S Baker, Richard J Taylor iD, Robert Konrat iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2201910120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Thomas C Schwarz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Vienna 1030, Austria. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-synuclein (αS) is an intrinsically disordered protein whose functional ambivalence and protein structural plasticity are iconic. Coordinated protein recruitment ensures proper vesicle dynamics at the synaptic cleft, while deregulated oligomerization on cellular membranes contributes to cell damage and Parkinson’s disease (PD). Despite the protein’s pathophysiological relevance, structural knowledge is limited. Here, we employ NMR spectroscopy and chemical cross-link mass spectrometry on 14 N/ 15 N-labeled αS mixtures to provide for the first time high-resolution structural information of the membrane-bound oligomeric state of αS and demonstrate that in this state, αS samples a surprisingly small conformational space. Interestingly, the study locates familial Parkinson’s disease mutants at the interface between individual αS monomers and reveals different oligomerization processes depending on whether oligomerization occurs on the same membrane surface (cis) or between αS initially attached to different membrane particles (trans). The explanatory power of the obtained high-resolution structural model is used to help determine the mode-of-actionof UCB0599. Here, it is shown that the ligand changes the ensemble of membrane-bound structures, which helps to explain the success this compound, currently being tested in Parkinson’s disease patients in a phase 2 trial, has had in animal models of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseAnimalsMembranesCell MembraneMagnetic Resonance SpectroscopyAntiparkinson Agents

Stichwörter der Autor:innen

UCB0599XL-MSoligomeric structureparamagnetic NMR spectroscopyα-synuclein

Substanzen

alpha-SynucleinAntiparkinson Agents

Autor:innen und Institutionen

  • Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Vienna 1030, Austria.
  • Department of Structural and Computational Biology, Christian Doppler Laboratory for High-Content Structural Biology and Biotechnology, University of Vienna, Vienna 1030, Austria.
  • Mass Spectrometry Facility, Max Perutz Labs, Vienna BioCenter, Vienna 1030, Austria.
  • UCB Pharma, Slough SL1 3WE, United Kingdom.

ORCID-Profile: Thomas C Schwarz, Karin Ledolter, Markus Hartl, Richard J Taylor, Robert Konrat

Zitieren

APA

Schwarz, T. C., Beier, A., Ledolter, K., Gossenreiter, T., Höfurthner, T., Hartl, M., Baker, T. S., Taylor, R. J., & Konrat, R. (2023). High-resolution structural information of membrane-bound α-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2201910120

Vancouver

Schwarz TC, Beier A, Ledolter K, Gossenreiter T, Höfurthner T, Hartl M, et al. High-resolution structural information of membrane-bound α-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2201910120

BibTeX
@article{Schwarz2023,
  author = {Schwarz, Thomas C and Beier, Andreas and Ledolter, Karin and Gossenreiter, Thomas and Höfurthner, Theresa and Hartl, Markus and Baker, Terry S and Taylor, Richard J and Konrat, Robert},
  title = {High-resolution structural information of membrane-bound α-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2201910120}
}
Kostenlos starten →